ERYtech Pharma: Prospectus Made Available After Obtaining Visa N° 14-566 From The French Financial Markets Authority
ERYTECH (Paris:ERYP) (Euronext Paris: FR0011471135 - ERYP), the French biopharmaceutical company that develops innovative ‘tumor starvation’ treatments for acute leukemia and other oncology indications with unmet medical need, announces today it obtained the visa for its Prospectus.
Help employers find you! Check out all the jobs and post your resume.
Help employers find you! Check out all the jobs and post your resume.